[Skip to content]
 Home
 News Index
 Our researched articles
 Science (General)
   List of studies
   Basic guide to EMFs
   EMF guidance levels
   RF unit conversion
   FAQs
   Other resources
 ELF ("Power" EMFs)
   Overview
   Powerlines
   Substations
   Electrical wiring
   Electrical appliances
 RF ("Microwave" EMFs)
   Overview
   WiFi
   Mobile phones
   Cordless phones
   Mobile phone masts
   Other resources
 Health
   Childhood leukaemia
   Brain tumours
   Electromagnetic sensitivity
   Other health effects
 Action
   Reduce your exposure
   - Mobile phones
   - Phone masts
   - Powerlines

Valid XHTML 1.0! Valid CSS!

- Liability disclaimer -
- Privacy policy -
- Cookies policy -
© Copyright Powerwatch 2024

Lloyd Morgan's Column

[Return to column index]

Commentary on a Study of the Risk of Brain Tumors from Cellular and Cordless Phone Use

Hardell et al., Pooled analysis of two case-control studies on the use of cellular and cordless telephone and the risk of benign brain tumours during 1997-2003;
International Journal of Oncology 28: 509-518, 2006

This study combined the results of two previously published papers. The total number of brain tumor cases participating in the study was 1,429. The total number of controls was 2162 matched to the cases by age, sex, SEI (Social Economic Index, a measure of wealth), year of diagnosis and region within Sweden. Cases were diagnosed between 1997 and 2003. The percentage of the Swedish population that used cellphones during this period was around 30% in 1997 and grew to over 95.5% by 2003.

The study's main finding was the risk of acoustic neuroma. It also reported a risk of the meningioma. Interestingly, among the ways they examined these risks was to look at the combinations of phone types that were used. Here is a summary of these findings:

Phone Type Acoustic Neuroma Meningioma
Risk % Confidence Risk % Confidence
Analog + digital cellphones 3.3 99.99990% 1.3 87%
Analog cellphones + cordless phones 3.9 99.999998% 1.7 99.6%
Digital cellphones + cordless phones 1.6 97.5% 1.2 80%
Analog + digital cellphones + cordless phones 4.1 99.99994% 1.7 98.6%
Any combination 1.5 99.3% 1.5 99.3%

Bold indicates a statistically significant risk (>95% confidence).

Of particular interest is that the authors report - the only study to do so to date - risk of acoustic neuroma for > 10-15 years (risk = 2.9, 99.7% confidence) and for > 15 years (risk = 3.8, 99.3% confidence). The graph below shows the percentage of increased risk of acoustic neuromas by years of cellphone use.

Risk of Acoustic Neuroma by Years of Cellphone Use

Unlike the Interphone series of cellphone studies, which had a large proportion of controls who refused to participate in the study, this study had nearly identical participation rates between cases (87.8%) and controls (88.7%). Such high and similar participation rates minimize problems that can cause an underestimation of risk.

In contrast, the Interphone series of studies on the risk of brain tumors from cellphone use has consistently had poor participation rates. For example, a recently published UK Interphone study had participation rates of 51% for glioma cases (30% had died by the time they were contacted) and 45% for the participating controls (29% refused to participate). [1]

As mentioned, the problem with poor participation rates is that selection bias is likely to cause an underestimation of risk. In the UK study, with 30% of the glioma cases dying before they were able to participate, the effect was to strongly underestimate the risk of high-grade glioma from cellphone use. Similarly, with only 45% of the controls participating there is a strong likelihood of a selection bias problem that would underestimate the risk of brain tumors from cellphone use. Such selection bias would result if the participating controls used cellphones more frequently than non-participating controls.

References

[1] Hepworth et al., Mobile phone use and risk of glioma in adults: case-control study;
British Medical Journal, 19 January 2006
http://bmj.bmjjournals.com/cgi/content/abstract/bmj.38720.687975.55v1